Molina Healthcare, Inc. (MOH) - Q3 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2024. Molina Healthcare, Inc. provides managed healthcare services primarily under Medicaid, Medicare, and state insurance Marketplaces. As of the reporting date, the company served approximately 5.6 million members across 21 states. The company operates four reportable segments: Medicaid, Medicare, Marketplace, and Other.
Key Financial Metrics
| Metric (in millions, except per share) | Q3 2024 | Q3 2023 | 9M 2024 | 9M 2023 |
|---|---|---|---|---|
| Total Revenue | $10,340 | $8,548 | $30,151 | $25,024 |
| Premium Revenue | $9,694 | $8,240 | $28,644 | $24,167 |
| Net Income | $326 | $245 | $928 | $875 |
| Diluted EPS | $5.65 | $4.21 | $15.97 | $15.08 |
| Operating Income | $467 | $359 | $1,327 | $1,257 |
| Medical Care Ratio (MCR) | 89.2% | 88.7% | 88.8% | 87.8% |
| General & Admin (G&A) Ratio | 6.5% | 7.1% | 6.9% | 7.3% |
| Cash & Cash Equivalents | $4,732 | $5,565 | $4,732 | $5,565 |
| Long-Term Debt | $2,332 | $2,180 | $2,332 | $2,180 |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 21% year-over-year in Q3 2024, driven by an 18% increase in premium revenue. This growth is attributed to new Medicaid contract wins, acquisitions (Bright Health Medicare, My Choice Wisconsin), and organic membership growth, partially offset by Medicaid redeterminations.
- Profitability: Net income rose 33% in Q3 2024 compared to Q3 2023. The increase was driven by higher premiums, improved G&A expense ratios, and increased investment income, despite a rise in the Medical Care Ratio (MCR).
- Medical Costs: The consolidated MCR increased to 89.2% in Q3 2024 (up 50 basis points from prior year). The increase was primarily due to higher-than-expected medical costs in the Medicaid and Medicare segments, including elevated pharmacy and long-term services and supports (LTSS) costs.
- Investment Income: Investment income increased 5% to $118 million in Q3 2024, bolstered by higher average yields on the investment portfolio.
- Acquisitions: The company closed the acquisition of Bright Health Medicare in January 2024, adding approximately 109,000 members. A definitive agreement was also announced to acquire ConnectiCare for approximately $350 million, expected to close in Q1 2025.
Guidance, Outlook, and Risks
- Membership Outlook: The company expects net membership additions of approximately 50,000 in Q4 2024 due to reconnects following Medicaid redeterminations. Management estimates retaining approximately 35% of the membership gained since March 2020.
- Capital Allocation: In October 2024, the Board authorized a new $1 billion share repurchase program extending through December 31, 2025. In Q3 2024, the company repurchased approximately 1.5 million shares for $500 million.
- Liquidity: The company amended its credit facility in September 2024, increasing available commitments to $1.25 billion. As of September 30, 2024, available borrowing capacity was $1.1 billion.
- Risks and Contingencies:
- Regulatory: Ongoing Medicaid redeterminations and potential retroactive rate adjustments (e.g., California) impact revenue and margins.
- Legal: Pending litigation includes a Virginia Medicaid contract dispute (Molina filed suit after losing a procurement bid) and a Texas Qui Tam action regarding STAR+PLUS assessments.
- Cybersecurity: The company experienced operational delays due to the Change Healthcare cybersecurity incident in February 2024 but reported no material financial impact to date.
Key Facts for Investor Verification
- Contract Renewals: Verify the status of the Virginia Medicaid contract dispute and the final terms of the new Florida and Michigan Medicaid contracts commencing in 2025.
- Medical Cost Trends: Monitor the trajectory of the Medical Care Ratio (MCR), particularly in the Medicaid segment, as it remains above the company's long-term target range due to acuity shifts and utilization.
- Acquisition Integration: Track the integration progress and financial performance of the Bright Health Medicare acquisition and the regulatory approval timeline for the ConnectiCare acquisition.
- Share Repurchases: Confirm the execution of the new $1 billion share repurchase program authorized in October 2024.
- Investment Portfolio: Review the impact of interest rate fluctuations on the fair value of the company's $4.5 billion investment portfolio, noting that unrealized losses are primarily due to interest rates rather than credit deterioration.